The Ghana Renal Registry – a first annual report by Boima, Vincent et al.
19
Original article
The Ghana Renal Registry – a first annual report
Vincent Boima1,2, Elliot K Tannor3,4, Charlotte Osafo1, Yaw Asante Awuku5, Michael Mate-Kole1, M Razeen Davids6,  
Dwomoa Adu1
1University of Ghana Medical School, University of Ghana, Accra, Ghana; 2Korle-Bu Teaching Hospital, Accra, Ghana; 3School of Medical 
Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; 4Komfo Anokye Teaching Hospital, Kumasi, Ghana; 
5Cape Coast Teaching Hospital, Cape Coast, Ghana. 6Division of Nephrology, Stellenbosch University and Tygerberg Hospital,  
Cape Town, South Africa.
AbsTRAcT
There are few data on the treatment of kidney disease in sub-Saharan Africa and no formal reports of kidney 
replacement therapy (KRT) in Ghana. We report data from the newly established Ghana Renal Registry on the 
prevalence, causes, and modality of treatment of kidney disease in Ghana. Using the web-based data capture system 
of the African Renal Registry, data were obtained for patients who had KRT in Ghana between January and 
December 2017. A total of 201 patients started KRT, giving an incidence rate of 6.9 per million population (pmp). 
There were 687 patients on KRT, a prevalence rate of 23.6 pmp. The median age of prevalent patients was 45.5 
years and 63.6% were male.  Hypertensive kidney disease was the most common primary kidney disease, reported 
in 39.9%. The overwhelming majority of patients (96.2%) were treated with haemodialysis, 3.5% had a kidney 
transplant, and only two were on continuous ambulatory peritoneal dialysis. The incidence and prevalence of KRT-
treated kidney failure in Ghana is low, and the patients are younger than those on KRT in high- and upper-middle-
income countries. The major cause of kidney failure is hypertensive kidney disease and the vast majority of the 
patients are treated with haemodialysis.
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INTRODUcTION
The increasing prevalence of non-communicable diseases 
combined with a high prevalence of communicable 
diseases threatens the lives of many people in sub-
Saharan Africa (SSA) and is likely to overwhelm the 
already inadequate health budgets of most African 
countries.  Chronic kidney disease (CKD) is common in 
SSA, with systematic reviews estimating the prevalence in 
adults to be between13.9% and 15.8% [1,2].  In Ghana, 
the CKD prevalence is comparable at 13.3% [3].  Patients 
with CKD are at increased risk of developing kidney 
failure as well as cardiovascular disease, which is 
associated with increased morbidity and mortality.   
There are few data on the incidence of kidney failure in 
SSA, but one study estimates this to be 239 per million 
population (pmp) in patients with diabetes mellitus and 
hypertension [4].  Most Africans who develop kidney 
failure are not able to access chronic dialysis and trans-
plantation services. According to a recent systematic 
review, approximately half of the patients so affected had 
at least one dialysis session, but only 10% were able to 
continue dialysis beyond three months and only 1% 
continued dialysis for one year [5].  
The major causes of kidney failure in Africa include 
hypertensive kidney disease, glomerulonephritis, diabetes, 
and HIV infection [6-10]. Renal registries that provide 
data on the burden of kidney failure, its treatment modali-
ties and outcomes are critical to the planning and delivery 
of effective services for KRT. With the exception of 
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South Africa [11], there are few active renal registries in 
Africa. To address this deficiency, the African Association 
of Nephrology (AFRAN), at its 2013 Congress in Accra, 
Ghana, took the decision to establish a renal registry for 
Africa. The African Renal Registry was formally established 
at a workshop held just before the World Congress of 
Nephrology in Cape Town, in 2015 [12].  Arising from this 
initiative, the Ghana Renal Registry was established in 2016 
and here we report its first set of data, from 2017.
METHODs
This was a prospective survey of all patients on KRT in 
Ghana between 1 January and 31 December 2017. We 
used the web-based data capture platform of the African 
Renal Registry, developed by the South African Renal 
Registry [12], which resides on a Windows 10 server, runs 
Windows Internet Information Services (IIS) and uses 
HyperFileSQL as its relational database engine. Data cap-
turers interface with the database via user-friendly web 
pages. Password protection ensures that treatment centres 
have access to their own data only. Data files are backed up 
daily and the full registry application is backed up weekly. 
Quality control is built into the system through logical 
checks, form field validation, and the use of controls such as 
checkboxes, radio buttons and drop-down lists, and limiting 
the number of fields which allow the entry of free text. 
The following core data were collected on each patient: 
region, dialysis centre, unique identif ication number and 
name, date of birth, sex, ethnicity (tribe), primary kidney 
disease, date KRT started, f irst modality of treatment, 
current modality, sector (private or public), diabetes 
mellitus status (non-diabetic, type 1 or 2 diabetes mellitus, 
post-transplant diabetes mellitus), hepatitis B, hepatitis C, 
and HIV status. The African Renal Registry uses the latest 
set of diagnostic codes of the ERA–EDTA Registry [13]. 
Data were extracted from patient records and entered 
directly into the registry. 
Numerical data have been summarised using means and 
standard deviations if normally distributed, and medians 
and interquartile ranges (IQR) if not. Counts and pecentages 
have been used for categorical data. In keeping with the 
descriptive nature of this report, statistical tests for dif-
ferences between groups have not been performed. 
Ethics approval, including a waiver of individual informed 




Ghana is a lower-middle-income country and had a gross 
national income per capita for 2017 by the Atlas method 
(current US$) of $1 890 and by the purchasing power 
parity (PPP) method (current international US$) of 
$4 860 [14]. The Ghanaian health system includes public 
institutions under the Ghana Health Service, teaching 
hospitals which are controlled by the Ministry of Health, 
and several private health centres mostly situated in the 
urban areas. The population in 2017 was estimated at 29.1 
million [15]. Of the 16 regions in Ghana, most of these 
hospitals and health centres are located in two main regions 
(greater Accra and Ashanti), where most patients with 
kidney disease receive their care.  
Treatment centres 
Only five of the 16 regions in Ghana have dialysis centres, 
namely Greater Accra, Ashanti, Northern, Central and the 
Volta Region (Figure 1). Seven treatment centres out of a 
total of nine which were operating in 2017 contributed 
data for this report; four in the public healthcare sector and 
three in the private sector. These centres reported on all 
patients under their care in 2017. The two centres that did 
not submit data had a total of fewer than 50 patients on 
dialysis. The omission of data from these units gives at most 
a 7.3% variation in the incidence and prevalence data 
presented in this report. Most patients (83.4%) were 
treated in public sector centres. All trained nephrologists 
are in two teaching hospitals and have oversight responsi-
bility for some of the dialysis centres. 
Incidence and prevalence of kidney 
replacement treatment
There were 201 patients who started KRT for the first time 
in 2017, an incidence rate of 6.9 pmp. The total number of 
patients on KRT in 2017 was 687, a prevalence of 23.6 
pmp.
Treatment modality
Of the patients on KRT, 661 (96.2%) were on haemodialysis, 
and only two patients were being treated with peritoneal 
dialysis (0.3%). There were 24 patients (3.5%) with a 
functioning kidney transplant.
Demographics 
The sex distribution of the patients on KRT reflected a 
male predominance (63.6%). The prevalence was 30.6 
pmp in males and 16.4 pmp in females. Patients were 
ghana renal registry report
21
generally young, with a median age of 45.5 years (IQR 
33.6–55.6 years). The age distribution is shown in Figure 2. 
Female patients were younger than their male counterparts, 
with median ages of 41.6 years (IQR 29.1–54.6 years) and 
46.8 years (IQR 37.2–56.4 years), respectively. The median 
age of patients treated in private sector units (51.5 years, 
IQR 39.8–61.0 years) was higher than in patients in the 
public sector units (43.8 years, IQR 32.9–54.6).  The median 
duration of time on dialysis was 25.4 months with an 
interquartile range of 10.5–44.5 months.
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causes of kidney failure
The most common cause of kidney failure (Table 1) was 
hypertensive kidney disease, reported in 37.8%, followed 
by kidney failure of uncertain cause in 28.5%, diabetic 
nephropathy in 9.2%, and glomerulonephritis in 7.7%.  HIV 
infection was present in 3.8% of the patients, 3.9% were 
hepatitis B surface antigen positive, and 0.8% were hepatitis 
C antibody positive. 
DIscUssION
In 2017, the incidence rate of patients starting KRT in 
Ghana was 7 pmp, which was much lower than the rate of 
26 pmp reported in South Africa [8] and 127 pmp in 
Europe [16].  The prevalence of KRT in Ghana was 24 pmp 
and again this was much lower than the 183 pmp reported 
from South Africa [8] and the 854 pmp reported from 
Europe [17]. The low rates of KRT in Ghana are likely to 
reflect the situation in many African countries where 
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Table 1.  causes of kidney failure in patients receiving kidney replacement therapy in ghana. 





Hypertensive kidney disease 187 (42) 73 (31) 260 (38)
Diabetic nephropathy 34 (8) 29 (12) 63 (9)
Glomerulonephritis 29 (6) 24 (10) 53 (8)
Uncertain or not stated 133 (30) 63 (27) 196 (29)
Cystic kidney disease 3 (1) 2 (1) 5 (1)
Obstruction or reflux disease 4 (1) 3 (1) 7 (1)
Sickle cell disease 0 2 (1) 2 (0)
SLE* 0 3 (1) 3 (0)
HIV 20 (4) 6 (3) 26 (4)
All others 41 (9) 31 (13) 72 (11)
Total 451 236 687
*Abbreviations: SLE, systemic lupus erythematosus; HIV, human immunodeficiency virus.
Figure 2.  age and sex distribution of ghanaian patients on kidney replacement therapy in 2017. 






















All          Male          Female
23
inadequate resources for health care limit the provision of 
KRT.  Most Ghanaian patients with kidney failure pay out of 
pocket for dialysis, putting KRT out of reach for most 
patients. Using data on the prevalence of diabetes and 
hypertension, Anand and colleagues have modelled the 
incidence of kidney failure in SSA, estimating it at 239 pmp 
[4]. In Ghana, this would translate into a substantial shortfall, 
with only 2.9% of patients needing KRT being treated.  
It is not clear why many more males than females received 
KRT. We speculate that this may be because women are 
disadvantaged in terms of accessing KRT in Ghana, although 
we have no evidence to support this. Alternatively, fewer 
women may develop kidney failure in Ghana. Future studies 
will examine these possibilities. Similarly, more males than 
females started KRT in the United Kingdom in 2016 (males 
62.9%) [18], South Africa (59.2 %) [8] and Europe (62%) 
[17]. A review by Carrero et al. in 2018 speculated that the 
protective effect of oestrogen on kidney function in women 
and the damaging role of testosterone in men might 
account for the higher proportion of men starting dialysis 
[19]. Further reasons are an unhealthy lifestyle in men and 
also that elderly women tended to choose conservative 
treatment more readily than men [19]. 
The patients on KRT in Ghana are young individuals, and 
even younger than reported from South Africa (median 
age of 45.5 versus 51.5 years) [8]. They are much younger 
than the average age of patients in the United Kingdom 
(64.3 years) [18] and Europe (63.1 years) [17]. Kidney 
failure in Ghana is thus a disease of young, economically 
active people.  Females on KRT were significantly younger 
than males; the reasons for this are unclear.
The principal reported cause of kidney failure was 
hypertensive kidney disease, followed by diabetes and 
glomerulonephritis. In Ghana, the prevalence of hyper-
tension has risen from 4% in rural areas and 13% in urban 
areas in the 1970s, to 24–27% and 33% in the 2000s, 
respectively [20]. Osafo et al. reported an overall CKD 
prevalence in Ghanaian patients with hypertension of 
47% [21]. The high prevalence of hypertensive kidney 
disease we are reporting in patients on KRT is comparable 
to that of South Africa (35%) [8] and other African regions 
(17–35%) [6, 7, 22, 23] but much higher than the 6% 
reported by the UK Renal Registry [18]. The ERA–EDTA 
Registry reported that 12% of prevalent patients had 
hypertensive kidney disease [16]. In 1993, we reported an 
autopsy study in which  hypertensive kidney disease was 
the cause of kidney failure in 49% of cases [24].  
We now know that two apolipoprotein L1 (APOL1) 
susceptibility gene variants (G1 and G2) are associated 
with hypertension-attributed CKD, focal segmental 
glomerulosclerosis and HIV-associated nephropathy in 
individuals of African ancestry [25-28]. The currently 
available evidence suggests that many patients with “hyper-
tensive kidney disease” may have undiagnosed glomerular 
disease with secondary hypertension, rather than kidney 
disease resulting from primary hypertension [29]. 
Our report identifies diabetes mellitus as another major 
cause of kidney failure in Ghana. Interestingly, there were 
no cases of diabetic nephropathy reported in the autopsy 
series from 1993 [24].  Other studies from SSA also report 
diabetic nephropathy as an important cause of kidney 
failure in 4% to 15% of cases [6-8,10,22]. The prevalence of 
diabetes in Ghana has increased from less than 1% in the 
1960s [30] to 6% in the 2000s [31]. The same pattern is 
seen in other African countries [32]. 
Glomerulonephritis was reported as the cause of kidney 
failure in 8% of our cases, lower than expected. We pre-
viously demonstrated histologically proven glomeru-
lonephritis, mostly focal segmental glomerulosclerosis, in 
42% of patients in the 1993 autopsy study [24]. The low 
prevalence of glomerulonephritis in the present study is 
probably because most patients presented late, with 
advanced CKD, and did not have a kidney biopsy. A high 
proportion of our patients therefore have kidney failure of 
uncertain aetiology. Future registry reports will analyse 
these patients in more detail. HIV infection was found in 
4% of our patients; in contrast, in 1993, there were no 
cases of HIV recorded in our autopsy study. The national 
prevalence of HIV infection in Ghana in 2017 was 2% [33].
Limitations and challenges
For this first round of data collection, data were available 
from only seven of the nine dialysis units. Almost all patients 
presented late and required dialysis treatment on admission. 
This made it difficult to ascertain the cause of kidney failure 
reliably. The cause of the kidney failure was based on the 
clinical assessment of the attending physician as there were 
very few biopsies done. We did not analyse laboratory data 
for this report and do not yet have sufficient follow-up data 
to comment on survival and prognosis. 
cONcLUsIONs
This first report of the Ghana Renal Registry provides 
much-needed data on the treatment of kidney failure in 
Ghana. Subsequent reports will include coverage of a 
greater number of regions and will report on important 
outcomes such as patient survival.
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